Skip to main navigation

Overview
Corporate
News & Events
Stock Information
Financial Information
- SEC Filings
- Quarterly Results
IR Resources

News & Events

News Releases

News Releases

All
2023
2022
2021
2020
2019

2021.03.31

Adagene Reports Full Year 2020 Financial Results and Provides Corporate Updates

2021.03.29

Adagene Announces Clinical Advancement for ADG116

2021.03.16

Adagene Announces First Patients Dosed in Global Phase 1 Clinical Trial of ADG126, Lead SAFEbody™ Program

2021.02.11

Adagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option

2021.02.09

Adagene Inc. Announces Pricing of Initial Public Offering

Pagination

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Page 10
Current page 11
Page 12
Page 13
Page 14
Next page
Last page

Displaying 51 - 55 of 66

Shareholder Tools

© 2023 Adagene Inc.

Footer Bottom

Home
Privacy
Terms of Use
Contact
Site Credits
LinkedIn